{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T16:20:02Z","timestamp":1787761202585,"version":"build-2784847793"},"reference-count":33,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T00:00:00Z","timestamp":1781654400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["K23HL173648"],"award-info":[{"award-number":["K23HL173648"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Blood Vessels, Thrombosis &amp; Hemostasis"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.bvth.2026.100178","type":"journal-article","created":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T22:15:22Z","timestamp":1781907322000},"page":"100178","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Current practices of index hospitalization anticoagulant use in pediatric patients with acute myeloid leukemia"],"prefix":"10.1016","volume":"3","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2482-3015","authenticated-orcid":false,"given":"Abbey","family":"Elsbernd","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-4887-6590","authenticated-orcid":false,"given":"Natalie","family":"Grills","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6188-2658","authenticated-orcid":false,"given":"James W.","family":"Antoon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathryn E.","family":"Kyler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1173-2146","authenticated-orcid":false,"given":"Lucas E.","family":"Orth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9528-7379","authenticated-orcid":false,"given":"Timothy J.","family":"Savage","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7778-5887","authenticated-orcid":false,"given":"Matt","family":"Hall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6628-8949","authenticated-orcid":false,"given":"Jennifer L.","family":"Goldman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shannon L.","family":"Carpenter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.bvth.2026.100178_bib2","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1001\/jama.293.6.715","article-title":"Malignancies, prothrombotic mutations, and the risk of venous thrombosis","volume":"293","author":"Blom","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/j.bvth.2026.100178_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2022.103782","article-title":"Venous thromboembolism in cancer and cancer immunotherapy","volume":"178","author":"Kacimi","year":"2022","journal-title":"Crit Rev Oncol Hematol"},{"issue":"6","key":"10.1016\/j.bvth.2026.100178_bib4","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1007\/s11864-023-01089-w","article-title":"Thrombosis in acute myeloid leukemia: pathogenesis, risk factors and therapeutic challenges","volume":"24","author":"Olivi","year":"2023","journal-title":"Curr Treat Options Oncol"},{"issue":"1","key":"10.1016\/j.bvth.2026.100178_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.beha.2022.101352","article-title":"Cancer associated thrombosis in pediatric patients","volume":"35","author":"Barg","year":"2022","journal-title":"Best Pract Res Clin Haematol"},{"issue":"4","key":"10.1016\/j.bvth.2026.100178_bib6","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1111\/ejh.13920","article-title":"Early-onset venous thromboembolisms in newly diagnosed non-promyelocytic acute myeloid leukemia patients undergoing intensive induction chemotherapy","volume":"110","author":"Koschade","year":"2023","journal-title":"Eur J Haematol"},{"issue":"22","key":"10.1016\/j.bvth.2026.100178_bib7","doi-asserted-by":"crossref","first-page":"5640","DOI":"10.3390\/cancers14225640","article-title":"Predictors of early thrombotic events in adult patients with acute myeloid leukemia: a real-world experience","volume":"14","author":"Paterno","year":"2022","journal-title":"Cancers"},{"issue":"2","key":"10.1016\/j.bvth.2026.100178_bib8","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.thromres.2011.03.014","article-title":"Epidemiology of venous thromboembolism in children with malignant diseases: a single-center study of the Belarusian Center for Pediatric Oncology and Hematology","volume":"128","author":"Lipay","year":"2011","journal-title":"Thromb Res"},{"issue":"2","key":"10.1016\/j.bvth.2026.100178_bib9","doi-asserted-by":"crossref","first-page":"e30096","DOI":"10.1002\/pbc.30096","article-title":"Pediatric cancer-associated thrombosis: analysis from a tertiary care cancer center in India","volume":"70","author":"Dhariwal","year":"2023","journal-title":"Pediatr Blood Cancer"},{"issue":"18","key":"10.1016\/j.bvth.2026.100178_bib10","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1056\/NEJM196205032661802","article-title":"The quantitative relation between platelet count and hemorrhage in patients with acute leukemia","volume":"266","author":"Gaydos","year":"1962","journal-title":"N Engl J Med"},{"issue":"10","key":"10.1016\/j.bvth.2026.100178_bib11","doi-asserted-by":"crossref","first-page":"2587","DOI":"10.1182\/bloodadvances.2024015328","article-title":"American Society of Hematology\/International Society on Thrombosis and Haemostasis 2024 updated guidelines for treatment of venous thromboembolism in pediatric patients","volume":"9","author":"Monagle","year":"2025","journal-title":"Blood Adv"},{"issue":"16","key":"10.1016\/j.bvth.2026.100178_bib12","doi-asserted-by":"crossref","first-page":"3063","DOI":"10.1200\/JCO.23.00294","article-title":"Venous thromboembolism prophylaxis and treatment in patients with cancer: ASCO guideline update","volume":"41","author":"Key","year":"2023","journal-title":"J Clin Oncol"},{"issue":"4","key":"10.1016\/j.bvth.2026.100178_bib13","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1182\/bloodadvances.2020003442","article-title":"American Society of Hematology 2021 guidelines for management of venous thromboembolism: prevention and treatment in patients with cancer","volume":"5","author":"Lyman","year":"2021","journal-title":"Blood Adv"},{"issue":"1","key":"10.1016\/j.bvth.2026.100178_bib15","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1111\/j.1365-2141.2011.08922.x","article-title":"The pathogenesis and management of the coagulopathy of acute promyelocytic leukaemia","volume":"156","author":"Breen","year":"2012","journal-title":"Br J Haematol"},{"issue":"3","key":"10.1016\/j.bvth.2026.100178_bib16","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1542\/peds.2015-1386","article-title":"Costs of venous thromboembolism, catheter-associated urinary tract infection, and pressure ulcer","volume":"136","author":"Goudie","year":"2015","journal-title":"Pediatrics"},{"issue":"3","key":"10.1016\/j.bvth.2026.100178_bib17","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2021-054649","article-title":"The continued rise of venous thromboembolism across US children\u2019s hospitals","volume":"149","author":"O\u2019Brien","year":"2022","journal-title":"Pediatrics"},{"key":"10.1016\/j.bvth.2026.100178_bib18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.thromres.2019.02.001","article-title":"Primary thromboprophylaxis in hospitalized children: a multi-center retrospective analysis","volume":"176","author":"Amos","year":"2019","journal-title":"Thromb Res"},{"issue":"3","key":"10.1016\/j.bvth.2026.100178_bib19","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1097\/00043426-199608000-00022","article-title":"Renal venous thrombosis complicating acute myeloid leukemia with hyperleukocytosis","volume":"18","author":"Murray","year":"1996","journal-title":"J Pediatr Hematol Oncol"},{"issue":"4","key":"10.1016\/j.bvth.2026.100178_bib20","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1007\/s00277-022-04770-6","article-title":"Frequency and risk factors for thrombosis in acute myeloid leukemia and high-risk myelodysplastic syndromes treated with intensive chemotherapy: a two centers observational study","volume":"101","author":"Martella","year":"2022","journal-title":"Ann Hematol"},{"key":"10.1016\/j.bvth.2026.100178_bib21","doi-asserted-by":"crossref","DOI":"10.3389\/fped.2022.828702","article-title":"Thrombosis complications in pediatric acute lymphoblastic leukemia: risk factors, management, and prevention: is there any role for pharmacologic prophylaxis?","volume":"10","author":"Rodriguez","year":"2022","journal-title":"Front Pediatr"},{"issue":"2-3","key":"10.1016\/j.bvth.2026.100178_bib22","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0049-3848(03)00099-9","article-title":"An open-label randomized controlled trial of low molecular weight heparin for the prevention of central venous line-related thrombotic complications in children: the PROTEKT trial","volume":"109","author":"Massicotte","year":"2003","journal-title":"Thromb Res"},{"issue":"4","key":"10.1016\/j.bvth.2026.100178_bib23","doi-asserted-by":"crossref","first-page":"756","DOI":"10.3324\/haematol.2018.194175","article-title":"THROMBOTECT\u2013a randomized study comparing low molecular weight heparin, antithrombin and unfractionated heparin for thromboprophylaxis during induction therapy of acute lymphoblastic leukemia in children and adolescents","volume":"104","author":"Greiner","year":"2019","journal-title":"Haematologica"},{"issue":"12","key":"10.1016\/j.bvth.2026.100178_bib24","doi-asserted-by":"crossref","first-page":"2034","DOI":"10.1055\/s-0039-1697027","article-title":"Effectiveness and safety of primary thromboprophylaxis in children with cancer: a systematic review of the literature and network meta-analysis","volume":"119","author":"Pelland-Marcotte","year":"2019","journal-title":"Thromb Haemost"},{"issue":"22","key":"10.1016\/j.bvth.2026.100178_bib25","doi-asserted-by":"crossref","first-page":"5821","DOI":"10.1182\/bloodadvances.2022008160","article-title":"Anticoagulation in pediatric cancer\u2013associated venous thromboembolism: a subgroup analysis of EINSTEIN-Jr","volume":"6","author":"Palumbo","year":"2022","journal-title":"Blood Adv"},{"issue":"1","key":"10.1016\/j.bvth.2026.100178_bib26","doi-asserted-by":"crossref","first-page":"e27","DOI":"10.1016\/S2352-3026(23)00314-9","article-title":"Apixaban versus no anticoagulation for the prevention of venous thromboembolism in children with newly diagnosed acute lymphoblastic leukaemia or lymphoma (PREVAPIX-ALL): a phase 3, open-label, randomised, controlled trial","volume":"11","author":"O'Brien","year":"2024","journal-title":"Lancet Haematol"},{"issue":"18","key":"10.1016\/j.bvth.2026.100178_bib27","doi-asserted-by":"crossref","first-page":"4738","DOI":"10.1182\/bloodadvances.2025016160","article-title":"Safety and efficacy of apixaban thrombosis prevention in pediatric patients with obesity and acute lymphoblastic leukemia","volume":"9","author":"Rodriguez","year":"2025","journal-title":"Blood Adv"},{"issue":"14","key":"10.1016\/j.bvth.2026.100178_bib28","doi-asserted-by":"crossref","first-page":"1854","DOI":"10.1182\/blood-2016-02-701094","article-title":"Disseminated intravascular coagulation at diagnosis is a strong predictor for thrombosis in acute myeloid leukemia","volume":"128","author":"Libourel","year":"2016","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.bvth.2026.100178_bib29","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1111\/j.1538-7836.2005.01467.x","article-title":"The risk of thrombosis in patients with acute leukemia: occurrence of thrombosis at diagnosis and during treatment","volume":"3","author":"De Stefano","year":"2005","journal-title":"J Thromb Haemost"},{"issue":"10","key":"10.1016\/j.bvth.2026.100178_bib30","first-page":"1181","article-title":"Cancer-associated venous thromboembolic disease, Version 2.2021, NCCN clinical practice guidelines in oncology","volume":"19","author":"Streiff","year":"2021","journal-title":"J Natl Compr Canc Netw"},{"issue":"4","key":"10.1016\/j.bvth.2026.100178_bib31","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1177\/1358863X15573839","article-title":"The validity of ICD codes coupled with imaging procedure codes for identifying acute venous thromboembolism using administrative data","volume":"20","author":"Alotaibi","year":"2015","journal-title":"Vasc Med"},{"issue":"12","key":"10.1016\/j.bvth.2026.100178_bib32","doi-asserted-by":"crossref","first-page":"e137","DOI":"10.1097\/MLR.0000000000000524","article-title":"Validity of using inpatient and outpatient administrative codes to identify acute venous thromboembolism: the CVRN VTE study","volume":"55","author":"Fang","year":"2017","journal-title":"Med Care"},{"issue":"suppl 1","key":"10.1016\/j.bvth.2026.100178_bib33","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1002\/pds.2341","article-title":"A systematic review of validated methods for identifying venous thromboembolism using administrative and claims data","volume":"21","author":"Tamariz","year":"2012","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"4","key":"10.1016\/j.bvth.2026.100178_bib34","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1111\/j.1538-7836.2005.01204.x","article-title":"Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients","volume":"3","author":"Schulman","year":"2005","journal-title":"J Thromb Haemost"},{"issue":"11","key":"10.1016\/j.bvth.2026.100178_bib35","doi-asserted-by":"crossref","first-page":"2852","DOI":"10.1111\/jth.15048","article-title":"Definition of major bleeding: prognostic classification","volume":"18","author":"Franco","year":"2020","journal-title":"J Thromb Haemost"}],"container-title":["Blood Vessels, Thrombosis &amp; Hemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2950327226000434?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2950327226000434?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T15:26:10Z","timestamp":1787757970000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2950327226000434"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":33,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["S2950327226000434"],"URL":"https:\/\/doi.org\/10.1016\/j.bvth.2026.100178","relation":{},"ISSN":["2950-3272"],"issn-type":[{"value":"2950-3272","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Current practices of index hospitalization anticoagulant use in pediatric patients with acute myeloid leukemia","name":"articletitle","label":"Article Title"},{"value":"Blood Vessels, Thrombosis & Hemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bvth.2026.100178","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 American Society of Hematology. Published by Elsevier Inc. Licensed under Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0), permitting only noncommercial, nonderivative use with attribution. All other rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"100178"}}